Search
Sharan Murugan
- Jul 31
- 3 min
USFDA Guidance: User Fee Programs: GDUFA, BSUFA, OMOR, and MDUFA
On July 31, 2024 the U.S. Food and Drug Administration (FDA) recently published in the Federal Register notice (FRN) the User Fee Rates...
27 views0 comments
Sharan Murugan
- Aug 1, 2023
- 2 min
USFDA Guidance: Assessing User Fees -BsUFA III: Biosimilar User Fee Amendments of 2022
Today (31 July 2023) the United States Food & Drug Administration's Center for Biologics Evaluation and Research and Center for Drug...
13 views0 comments
Sharan Murugan
- Nov 1, 2022
- 1 min
USFDA Guidance: Expanded Access to IND Q&A and Assessing User Fees under OMUFA
Earlier Today (1-November-2022), the U.S. Food and Drug Administration issued a revised draft guidance for the industry, “Expanded Access...
33 views0 comments
Sharan Murugan
- Mar 15, 2022
- 1 min
FDA's: OTC Monograph Drug User Fees for Fiscal Year 2022
Yesterday USFDA published the fees for over-the-counter (OTC) monograph drugs for fiscal year (FY) 2022 in a Federal Register Notice...
12 views0 comments
Sharan Murugan
- Aug 13, 2021
- 2 min
FY2022 User Fee Table -USFDA
The User Fee programs help the Food and Drug Administration (FDA) to fulfill its mission of protecting public health and accelerating...
80 views0 comments